Notable Analyst Rating Changes 12/03: (ABBV) (AAPL) (FRX) Upgraded; (PFE) (DIS) (AT) Downgraded
Tweet Send to a Friend
UPGRADES
Goldman Sachs adds AbbVie (NYSE: ABBV) to its Conviction Buy, while its price target was adjusted from $57 to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs adds AbbVie (NYSE: ABBV) to its Conviction Buy, while its price target was adjusted from $57 to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
